Cystinuria-Diagnosis and Management

EAU-EBU Update Series

Volumn 4, Issue 5, 2006, Pages 175-183

  Biyani, Chandra S ^a   Cartledge, Jon J ^b  

^a PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cystinuria; Diagnosis; Genetics; Medical management

Indexed keywords

ACETYLCYSTEINE; AMPICILLIN; BICARBONATE; BUCILLAMINE; CAPTOPRIL; CARRIER PROTEIN; CITRATE POTASSIUM; CYSTINE; PENICILLAMINE; PROTEIN SLC3A1; PYRIDOXINE; THIOL DERIVATIVE; TIOPRONIN; UNCLASSIFIED DRUG;

ALKALINIZATION; AMINO ACID TRANSPORT; ARTHRALGIA; AUTOSOMAL RECESSIVE DISORDER; CHROMOSOME 2P; COOPERATION; CYSTINURIA; DIAGNOSTIC IMAGING; DIET THERAPY; DISEASE CLASSIFICATION; DRUG ERUPTION; DRUG FORMULATION; DRUG MECHANISM; EXTRACORPOREAL LITHOTRIPSY; FLUID INTAKE; GASTROINTESTINAL SYMPTOM; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HYDRATION; HYPERTENSION; KIDNEY PROXIMAL TUBULE; LASER LITHOTRIPSY; LEUKOPENIA; MINIMALLY INVASIVE SURGERY; NEPHRITIS; NEPHROLITHOTOMY; NEPHROLOGIST; NEPHROSTOMY; PATIENT CARE; PYRIDOXINE DEFICIENCY; RADIOLOGIST; REVIEW; SMALL INTESTINE; SOLUBILITY; STONE ANALYSIS; STONE FORMATION; SURGICAL APPROACH; UNSPECIFIED SIDE EFFECT; URINALYSIS; URINE; UROLOGICAL PROCEDURES; UROLOGY;

EID: 33748249009     PISSN: 18712592     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eeus.2006.06.001     Document Type: Review

References (51)

1. Rosenberg L.E., Durant J.L., and Holland J.M. Intestinal absorption and renal extraction of cystine and cysteine in cystinuria. N Engl J Med 273 (1965) 1239-1245
2. Crawhall J.C., Scowen E.F., and Thompson C.S. The renal clearance of amino acids in cystinuria. J Clin Invest 46 (1967) 1162-1171
3. Schafer J.A., and Watkins M.L. Transport of L-cystine in isolated perfused proximal straight tubules. Pflugers Arch 401 (1984) 143-151
4. Silbernagl S. The renal handling of amino acids and oligopeptides. Physiol Rev 68 (1988) 911-1007
5. Rutchik S.D., and Resnick M.I. Cystine calculi. Diagnosis and management. Urol Clin North Am 24 (1997) 163-171
6. Levy H. Genetic screening. In: Herns H., and Hirschorn K. (Eds). Advances in Human Genetics (1973), Plenum, New York 1-82
7. Shekarriz B., and Stoller M.L. Cystinuria and other noncalcareous calculi. Endocrinol Metab Clin N Am 31 (2002) 951-977
8. Their S.O., and Halperin E.C. Cyatinuria. In: Coe F.L. (Ed). Nephrolithiasis (1980), Churchill Livingstone, New York 208-230
9. Thier S.O., Segal S., Fox M., Blair A., and Rosenberg L.E. Cystinuria: defective intestinal transport of dibasic amino acids and cystine. J Clin Invest 44 (1965) 442-448
10. Dent C.E., and Senior B. Studies on the treatment of cystinuria. Br J Urol 27 (1955) 317-332
11. Pak C.Y., and Fuller C.J. Assessment of cystine solubility in urine and of heterogeneous nucleation. J Urol 129 (1983) 1066-1070
12. Rosenberg L.E., Downing S., Durant J.L., and Segal S. Cystinuria: biochemical evidence for three genetically distinct diseases. J Clin Invest 45 (1966) 365-371
13. Palacin M., Borsani G., and Sebastio G. The molecular bases of cystinuria and lysinuric protein intolerance. Curr Opin Genet Dev 11 (2001) 328-335
14. Bertran J., Werner A., Chillaron J., et al. Expression cloning of a human renal cDNA that induces high affinity transport of L-cystine shared with dibasic amino acids in Xenopus oocytes. J Biol Chem 268 (1993) 14842-14849
15. Schmidt C., Vester U., Hesse A., et al. The population-specific distribution and frequencies of genomic variants in the SLC3A1 and SLC7A9 genes and their application in molecular genetic testing of cystinuria. Urol Res 32 (2004) 75-78
16. Pras E. Cystinuria at the turn of the millennium: clinical aspects and new molecular developments. Mol Urol 4 (2000) 409-414
17. 0,+)AT of rBAT. Nat Genet 23 (1999) 52-57
18. International Cystinuria Consortium. Functional analyses of mutations in SLC7A9, and genotype-phenotype correlation in non-type I cystinuria. Hum Mol Genet 10 (2001) 305-316
19. Dello Strologo L., Pras E., Pontesilli C., et al. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol 13 (2002) 2547-2553
20. Knoll T., Zöllner A., Wendt G., et al. Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20 (2005) 19-24
21. Brand E., Harris M.M., and Billon S. Cystinuria: excretion of a cystine complex which decomposes in the urine with the liberation of free cystine. J Biol Chem 86 (1930) 315-331
22. Sakhaee K., and Sutton R.A. Pathogenesis and medical management of cystinuria. In: Coe F.L., Favus M.J., and Pak C. (Eds). Kidney stones: Medical and Surgical Managements (1996), Lippincott-Raven, Philadelphia, Pa 1007-1017
23. Daudon M., Cohen-Solal F., Barbey F., et al. Cystine crystal volume determination: a useful tool in the management of cystinuric patients. Urol Res 31 (2003) 207-211
24. Coe F.L., Clark C., Parks J.H., and Asplin J.R. Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs. J Urol 166 (2001) 688-693
25. Goldfarb D.S., Coe F.L., and Asplin J.R. Urinary cystine excretion and capacity in patients with cystinuria. Kidney International 69 (2006) 1041-1047
26. Bhatta K.M., Prien Jr. E.L., and Dretler S.P. Cystine calculi-rough and smooth: a new clinical distinction. J Urol 142 (1989) 937-940
27. Jaeger P., Portmann L., Saunders A., et al. Anticystinuric effects of glutamine and of dietary sodium restriction. N Engl J Med 315 (1986) 1120-1123
28. Ng C.S., and Streem S.B. Contemporary management of cystinuria. J Endourol 13 (1999) 647-651
29. Joly D., Rieu P., Méjean A., et al. Treatment of cystinuria. Paed Nephrol 13 (1999) 945-950
30. Lindell A., Denneberg T., Hellgren E., Jeppsson J.O., and Tiselius H.G. Clinical course and cystine stone formation during tiopronin treatment. Urol Res 23 (1995) 111-117
31. Sakhaee K., Nicar M., Hill K., et al. Contrasting effects of potassium and sodium citrate therapies on urinary chemistries and crystallisations of stone forming salts. Kidney Int 24 (1983) 348-352
32. Crawhall J.C., Scowen E.F., and Watts R.W. Effect of penicillamine on cystinuria. Br Med J 5330 (1963) 588-590
33. Halperin E.C., Thier S.O., and Rosenberg L.E. The use of D-penicillamine in cystinuria: efficacy and untoward reactions. Yale J Biol Med 54 (1981) 439-446
34. Pak C.Y., Fuller C., Sakhaee K., et al. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol 136 (1986) 1003-1008
35. Sloand J.A., and Izzo Jr. J.L. Captopril reduces urinary cystine excretion in cystinuria. Arch Intern Med 147 (1987) 1409-1412
36. Kashiwazaki S., and Shiokawa Y. Bucillamine: a new immunomodulator. Int M J Immunother 3 (1987) 1-6
37. Koide T, Yamagushi S, Utsonomiya M, et al. A new therapeutic agent for cystinuria. In: Proceedings of the VII International Symposium on urolithiasis. Plenum, Cairns, Australia, 1992. p. 168.
38. Koide T., Yoshioka T., Miyake O., Okuyama A., and Yachiku S. Long-term study of tiopronin in patients with cystinuria. Hinyokika Kiyo 49 (2003) 115-120
39. Pareek G., Steele T.H., and Nakada S.Y. Urological intervention in patients with cystinuria is decreased with medical compliance. J Urol 174 (2005) 2250-2252
40. Cross W.R., Chahal R., Will E., and Cartledge J. Impact of a metabolic stone clinic on management of patients with cystinuria. BJU International 95 (2005) 38, P20
41. Kachel T.A., Vijan S.R., and Dretler S.P. Endourological experience with cystine calculi and a treatment algorithm. J Urol 145 (1991) 25-28
42. Katz G., Kovalski N., and Landau E.H. Extracorporeal shock wave lithotripsy for treatment of ureterolithiasis in patients with cystinuria. Br J Urol 72 (1993) 13-16
43. Knoll L.D., Segura J.W., Patterson D.E., et al. Long-term follow-up in patients with cystine urinary calculi treated by percutaneous ultrasonic lithotripsy. J Urol 140 (1988) 246-248
44. Chow G.K., and Streem S.B. Medical treatment of cystinuria: results of contemporary clinical practice. J Urol 156 (1996) 1576-1578
45. Dretler S.P., Pfister R.C., Newhouse J.H., and Prien Jr. E.L. Percutaneous catheter dissolution of cystine calculi. J Urol 131 (1984) 216-219
46. Saltzman N., and Gittes R.F. Chemolysis of cystine calculi. J Urol 136 (1986) 846-849
47. Lindell A., Denneberg T., and Granerus G. Studies on renal function in patients with cystinuria. Nephron 77 (1997) 76-85
48. Chow G.K., and Streem S.B. Contemporary urological intervention for cystinuric patients: immediate and long-term impact and implications. J Urol 160 (1998) 341-345
49. Parvex P., Rozen R., Dziarmaga A., and Goodyer P. Studies of urinary cystine precipitation in vitro: ontogeny of cystine nephrolithiasis and identification of meso-2,3-dimercaptosuccinic acid as a potential therapy for cystinuria. Mol Genet Metab 80 (2003) 419-425
50. Peters T., Thaete C., Wolf S., Popp A., et al. A mouse model for cystinuria type I. Hum Mol Genet 12 (2003) 2109-2120
51. Feliubadalo L., Arbones M.L., Manas S., et al. Slc7a9-deficient mice develop cystinuria non-I and cystine urolithiasis. Hum Mol Genet 12 (2003) 2097-2108